| Prev Close | 101.24 |
| Open | 100.79 |
| Day Low/High | 100.78 / 102.48 |
| 52 Wk Low/High | 72.67 / 125.52 |
| Volume | 584.68K |
Alexion Pharmaceuticals, Inc. (ALXN)
101.63
0.39
0.39
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 219.17B |
| Market Cap | 22.33B |
| P/E Ratio | 27.17 |
| Div & Yield | N.A. (N.A) |
Trader's Daily Notebook: Gusher for Oil Stocks
Big move for biotechs isn't pleasant.
Here’s Why Shares of Biogen and Alexion Tanked On Tuesday
Shares of Biogen and Alexion Pharmaceuticals took a hit Tuesday after their promising new products failed clinical trials.
Trending Tickers: Z, VRX, BIIB, ALXN
U.S. indices are up as oil continues its climb past $50 a barrel.
U.S. Futures and World Markets Blindsided by Bank of Japan Decision
Crude prices were also falling following the BOJ's decision to keep its monetary policy unchanged.
Alexion Pharmaceuticals' Big Top Foreshadows Big Drop
The next potential support levels are the $120 and $100 areas from 2013.
Novice Trade: Illumina
ILMN's three-month at-the-money implied volatility is at about the median level.
Deluge of Deals Isn't About to Dry Up
Acquisitions cut into overabundance of companies.
3 Fantastic Pharmaceutical Stocks: Abbvie, Vertex and Biogen
AbbVie is a cheap stock and worries about competition immediately hurting its rheumatoid arthritis drug Humira are overblown, said John Schroer, Portfolio Manager for the AllianzGI Health Sciences Fund.
Market Wrap: Yellen Delivers a Jolt
U.S. stocks fell for a second straight session.
Microsoft Lags Dow in Tech Selloff; Yellen Spooks Wall Street
Stocks pared losses, though remained in the red by close as markets weighed comments from Federal Reserve Chair Janet Yellen that equity valuations were possibly stretched.
Herbalife Beats Estimates; Stocks Open Slightly Higher as Crude Rallies
Herbalife (HLF) rallied after boosting full-year earnings forecasts as sales in China showed strength.
The 7 Pillars of Healthcare Strength
Here are healthcare stocks of all shares and sizes with strong charts.
Braving Biotech
Do you need to pick one name? Biotech has carried with it a lasting resiliency like few other sectors. Perhaps it is driven by optimism and hope. Perhaps it is driven by the fear of suffering or watching someone suffer from the very illnesses these ...
Those Sensitive Biotechs
They are prone to being whipsawed by news.
The Trader Daily
A few stocks that could break higher.
Why You Should Watch Fibonacci Extensions
As these examples illustrate, it's just good risk management.
Rules of the Game: No Slowdown in Health Care
Some growth leaders in the sector are getting technical support.
Off the Charts
Updating our current trade ideas.
Alexion Looks Promising
The stock seems liable to reenter its uptrend, so here's how to play it.
A Blueprint for Highflier Stability
Cautionary tales that the IPO window might be closing at last.
Off the Charts
Intel breaks above our target on Piper Jaffray upgrade.
Off the Charts
Ford rallies after March auto sales blow past Street view, surpassing our target.
Off the Charts
Alaska Air is trading above all key moving averages with a healthy uptrend since July.
